Cottonwood Capital Advisors LLC Acquires 726 Shares of The Cigna Group (NYSE:CI)

Cottonwood Capital Advisors LLC grew its holdings in The Cigna Group (NYSE:CI) by 80.4% in the 4th quarter, Holdings Channel reports. The fund owned 1,629 shares of the health services provider’s stock after purchasing an additional 726 shares during the quarter. Cottonwood Capital Advisors LLC’s holdings in The Cigna Group were worth $450,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. ORG Wealth Partners LLC acquired a new position in The Cigna Group during the 4th quarter valued at $34,000. Ulland Investment Advisors LLC increased its holdings in shares of The Cigna Group by 2,500.0% during the 3rd quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock worth $36,000 after purchasing an additional 100 shares during the period. Prospera Private Wealth LLC bought a new stake in shares of The Cigna Group in the third quarter valued at about $37,000. Harbor Capital Advisors Inc. bought a new stake in shares of The Cigna Group in the third quarter valued at about $45,000. Finally, Intact Investment Management Inc. acquired a new stake in The Cigna Group during the third quarter worth about $69,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

The Cigna Group Stock Performance

Shares of NYSE:CI opened at $294.18 on Friday. The business has a fifty day moving average of $297.72 and a 200-day moving average of $325.82. The firm has a market cap of $81.83 billion, a PE ratio of 27.75, a price-to-earnings-growth ratio of 0.78 and a beta of 0.54. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.72 and a current ratio of 0.72. The Cigna Group has a twelve month low of $262.03 and a twelve month high of $370.83.

The Cigna Group (NYSE:CI) last announced its earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share for the quarter, topping analysts’ consensus estimates of $7.22 by $0.29. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The company had revenue of $63.70 billion during the quarter, compared to the consensus estimate of $59.58 billion. During the same period in the previous year, the firm posted $6.77 earnings per share. The company’s revenue was up 29.8% on a year-over-year basis. On average, equities research analysts predict that The Cigna Group will post 28.5 EPS for the current fiscal year.

Wall Street Analyst Weigh In

CI has been the subject of several recent research reports. Royal Bank of Canada cut their price target on The Cigna Group from $384.00 to $377.00 and set an “outperform” rating for the company in a report on Friday, November 1st. StockNews.com cut The Cigna Group from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Deutsche Bank Aktiengesellschaft lowered their price target on shares of The Cigna Group from $398.00 to $394.00 and set a “buy” rating on the stock in a report on Monday, November 4th. Barclays upped their target price on shares of The Cigna Group from $405.00 to $420.00 and gave the company an “overweight” rating in a research note on Tuesday, November 5th. Finally, Piper Sandler restated an “overweight” rating and set a $394.00 price target (up previously from $392.00) on shares of The Cigna Group in a research note on Tuesday, November 5th. One equities research analyst has rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, The Cigna Group currently has a consensus rating of “Buy” and a consensus price target of $395.93.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.